Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 29c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.65), $0.29 better than the analyst estimate of ($0.94).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery